Author:
Goto M,Sugiyama M,Ishizaki T
Abstract
The pharmacokinetics of dibekacin, a new aminoglycoside antibiotic, was studied in volunteers given the same dose (100 mg) intramuscularly on two separate occasions and intravenously at two different rates of infusion. The kinetic parameters (t 1/2, 2.24 h, and Vd, 0.136 liter/kg, as the overall mean) observed after intramuscular administration appear to be compatible with those of other aminoglycosides and fairly reproducible within the same individuals. Dibekacin was rapidly absorbed (tmax, 0.84 h), yielding a peak level of 10.4 microgram/ml after the 100-mg intramuscular dose. After the 30- or 60-min infusion, the concentrations of dibekacin in serum fell bi-exponentially, giving an elimination half-life (t 1/2 beta) of 2.50 to 2.88 h. The highest serum levels after th 30- and 60-min infusions were 15.2 +/- 0.9 and 12.1 +/- 1.8 microgram/ml, respectively. Serum levels at 6 h after completion of infusions were 1.9 +/- 0.3 and 1.7 +/- 0.4 microgram/ml, respectively.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference26 articles.
1. Antimicrobial spectrum, pharmacology, and therapeutic use of antibiotics;Barza M.;IV. Aminoglycosides. Am. J. Hosp. Pharm.,1977
2. Feasibility of administering aminoglycoside antibiotics by continuous intravenous infusion;Bodey G. P.;Antimicrob. Agents Chemother.,1975
3. Comparative pharmacokinetics of BB-K8 and kanamycin in dogs and humans;Cabana B. E.;Antimicrob. Agents Chemother.,1973
4. Comparative pharmacokinetics of amikacin and kanamycin;Clarke J. T.;Clin. Pharmacol. Ther.,1974
5. A comparative trial of sisomicin therapy by intermittent versus continuous infusion;Feld R.;Am. J. Med. Sci.,1977
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献